Rewrite Bio

Rewrite Bio

United StatesUnited States
•Pre-Seed•Founded 2023•Updated 3w ago
Digital healthHealthtechBio Tech/Life SciencesAI/MLB2CB2B2C1-5 employees
Actively RaisingFemale FounderFemale Founder

About

Rewriting the standard of reproductive healthcare through precision biology. REWRITE shifts fertility care upstream by optimizing egg, sperm, and metabolic health using genetics and recurring biomarkers, reducing cost, invasiveness, and time to pregnancy while improving outcomes for couples trying to conceive.

Traction & Metrics

Users & Clients

15

Clients

Financial

$257K

ARR

Team

Alik

Alik

CEO

Jessica

Jessica

COO

Jason

Jason

CTO

Mike

Mike

Advisor

Rashmi

Rashmi

Advisor

Amanda

Amanda

Advisor

Priyanka

Priyanka

Advisor

Products

REWRITE Fertility Optimization Platform

A closed-loop precision fertility platform combining at-home genetic testing, targeted blood biomarker panels, and clinician-reviewed personalized guidance. The five-step process (Test, Translate, Act, Measure, Support) delivers a personalized meal plan, supplement protocol, and weekly habits via a shared dashboard, with a complimentary 6-month retest that updates recommendations as the body responds. Designed to slot into the gap between OB-GYN/primary care and fertility clinics, helping couples optimize egg, sperm, and metabolic health to improve natural conception rates and IVF outcomes while reducing cost and time to pregnancy.

Click to read more